Staburo @ DAGStat Conference 2019 Several Staburo statisticians attended the DAGStat Conference 2019. The fifth conference of the Deutsche Arbeitsgemeinschaft Statistik took place in the heart of the Bavarian capital, Munich, from March 18 - 22, 2019.According to the...

Training @ Staburo: How to measure the abundance of mRNA, using Microarrays and Sequencing TechnologiesThe normal function of cells depends on accurate expression of a large number of proteins. As it is difficult to measure the number of thousands of proteins...

Staburo @ BIO-M Workshop: Start thinking with the end in mind: Using the right Data in Clinical Development and Market AccessStaburo's Managing Director Roland Stieger attended the BioM seminar with the topic “Using the right Data in Clinical Development and Market...

Training @ Staburo: Adaptive Enrichment Design BiostatisticsDue to the growing interest in personalized medicine, where patients receive individually tailored therapies, the application of adaptive enrichment designs becomes increasingly more important.In standard...

Staburo supports OncologyInformationService in Data Analytics Staburo recently started a successful collaboration with OncologyInformationService - O.I.s)! Staburo supports O.I.s) in the analysis of Real World Data in oncology.O.I.s) has been providing an innovative,...

Training@Staburo: clustering in the context of precision medicine This presentation about clustering, differentiated between supervised and unsupervised methods, and introduced clustering as an important tool for subgroup identification, in the context of precision...

Staburo at the 12th IGSEE ForumStaburo participated at the career fair that was organised by the International Graduate School of Science and Engineering (IGSSE), at the TUM Science and Study Center in Raitenhaslach. The IGSSE, which has won the German Excellence...

Training@Staburo: How to use cross-validation to obtain reliable subgroup effectsNicole Krämer, project leader Translational Medicine and Biomarker, explained how we can use cross-validation to obtain reliable subgroup effects.The identification of patient...

Staburo @ EMA scientific advice meeting in London Staburo Managing Director Josef Höfler visited the European Medicines Agency (EMA) in London to have a scientific advice meeting, for a client's clinical development project. Statistical concepts for...